Steroid therapy in septic shock: survey of practice amongst UK critical care physicians

Corticosteroid (CS) therapy in sepsis remains controversial and was first introduced in sepsis management for its anti-inflammatory property. CS has found a role in septic shock amelioration with inconsistent outcomes. The Surviving Sepsis Campaign (SSC) includes CS as a Level 2C recommendation in septic shock [1]. Adapting and practicing SSC guidelines vary between critical care units. Accordingly, a survey was conducted to elucidate the usage of CS for septic shock by UK critical care physicians (CCPs).